Cargando…
A Robust PCR Protocol for HIV Drug Resistance Testing on Low-Level Viremia Samples
The prevalence of drug resistance (DR) mutations in people with HIV-1 infection, particularly those with low-level viremia (LLV), supports the need to improve the sensitivity of amplification methods for HIV DR genotyping in order to optimize antiretroviral regimen and facilitate HIV-1 DR surveillan...
Autores principales: | Gupta, Shivani, Taylor, Tracy, Patterson, Aileen, Liang, Binhua, Bullard, Jared, Sandstrom, Paul, Van Domselaar, Gary, Ji, Hezhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394351/ https://www.ncbi.nlm.nih.gov/pubmed/28473986 http://dx.doi.org/10.1155/2017/4979252 |
Ejemplares similares
-
A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance
por: Taylor, Tracy, et al.
Publicado: (2019) -
Prevalence of Primary Drug Resistance Against HIV-1 Integrase Inhibitors in Canada
por: Ji, Hezhao, et al.
Publicado: (2018) -
Pyrosequencing Dried Blood Spots Reveals Differences in HIV Drug Resistance between Treatment Naïve and Experienced Patients
por: Ji, Hezhao, et al.
Publicado: (2013) -
Overview of the Analytes Applied in Genotypic HIV Drug Resistance Testing
por: Ji, Hezhao, et al.
Publicado: (2022) -
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
por: Widera, Marek, et al.
Publicado: (2017)